Viral Enteric Infections in Acute Severe Ulcerative Colitis

被引:2
作者
Ostrowski, Szymon [1 ,2 ]
Croft, Anthony [1 ,3 ]
机构
[1] Royal Brisbane & Womens Hosp, Dept Gastroenterol & Hepatol, Butterfield St, Herston, Qld 4029, Australia
[2] Mater Hosp Brisbane, Dept Gastroenterol & Hepatol, Raymond Terrace, South Brisbane, Qld 4101, Australia
[3] Univ Queensland, St Lucia, Qld 4072, Australia
关键词
Microbiology; EVIDENCE-BASED CONSENSUS; INFLAMMATORY-BOWEL-DISEASE; OUTCOMES; MANAGEMENT; DIAGNOSIS; PROGNOSIS; THERAPY; ARTICLE;
D O I
10.1093/ecco-jcc/jjac028
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and Aims Excluding superimposed enteric infection is critical in the management of acute severe ulcerative colitis [ASUC]. Whilst infection with Clostridium difficile and cytomegalovirus have been shown to increase colectomy and mortality rates, no data exist regarding the impact of common viral enteropathogens in ASUC. Our aim was to determine if viral enteric infection in ASUC alters the severity or outcomes of these episodes. Methods This was a retrospective review of cases presenting to a large tertiary centre. Data were obtained from an in-house, prospectively maintained inflammatory bowel disease database. We identified all ASUC cases treated between October 2015 and January 2021 and compared those testing positive for adenovirus 40/41, human rotavirus or norovirus GI by faecal multiplex polymerase chain reaction [PCR] to those testing negative. Results We identified 147 patients with ASUC and faecal multiplex PCR testing for viral pathogens. In total, 22/147 patients [14.9%] tested positive, two of whom tested positive for two viruses. The infected and non-infected cohorts did not differ significantly with regard to admission C-reactive protein [81.7 vs 76.6, p = 0.77], Mayo endoscopic subscore [2.4 vs 2.3, p = 0.43], length of hospital admission [7.9 vs 7.9 p = 0.99], requirement for rescue therapy [59% vs 56%, p = 0.75] or colectomy rate [4.5% vs 4.1%, p = 0.69]. Conclusions Infection with viral enteropathogens was common in our ASUC cohort, but did not appear to affect disease severity at presentation, the need for rescue therapy or the success rate of rescue therapy.
引用
收藏
页码:1335 / 1339
页数:5
相关论文
共 33 条
[1]   Colectomy rate in acute severe ulcerative colitis in the infliximab era [J].
Aratari, A. ;
Papi, C. ;
Clemente, V. ;
Moretti, A. ;
Luchetti, R. ;
Koch, M. ;
Capurso, L. ;
Caprilli, R. .
DIGESTIVE AND LIVER DISEASE, 2008, 40 (10) :821-826
[2]   Enteric Infections Are Common in Patients with Flares of Inflammatory Bowel Disease [J].
Axelrad, Jordan E. ;
Joelson, Andrew ;
Green, Peter H. R. ;
Lawlor, Garrett ;
Lichtiger, Simon ;
Cadwell, Ken ;
Lebwohl, Benjamin .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 (10) :1530-1539
[3]   A Review of Mortality and Surgery in Ulcerative Colitis: Milestones of the Seriousness of the Disease [J].
Bernstein, Charles N. ;
Ng, Siew C. ;
Lakatos, Peter L. ;
Moum, Bjorn ;
Loftus, Edward V., Jr. .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (09) :2001-2010
[4]   Review article: acute severe ulcerative colitis - evidence-based consensus statements [J].
Chen, J-H. ;
Andrews, J. M. ;
Kariyawasam, V. ;
Moran, N. ;
Gounder, P. ;
Collins, G. ;
Walsh, A. J. ;
Connor, S. ;
Lee, T. W. T. ;
Koh, C. E. ;
Chang, J. ;
Paramsothy, S. ;
Tattersall, S. ;
Lemberg, D. A. ;
Radford-Smith, G. ;
Lawrance, I. C. ;
McLachlan, A. ;
Moore, G. T. ;
Corte, C. ;
Katelaris, P. ;
Leong, R. W. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 44 (02) :127-144
[5]   Predicting response after infliximab salvage in acute severe ulcerative colitis [J].
Choy, Matthew C. ;
Seah, Dean ;
Gorelik, Alexandra ;
An, Yoon-Kyo ;
Chen, Cheng-Yu ;
Macrae, Finlay A. ;
Sparrow, Miles P. ;
Connell, William R. ;
Moore, Gregory T. ;
Radford-Smith, Graham ;
Van Langenberg, Daniel R. ;
De Cruz, Peter .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (07) :1347-1352
[6]   Severe acute colitis associated with CMV:: a prevalence study [J].
Criscuoli, V ;
Casà, A ;
Orlando, A ;
Pecoraro, G ;
Oliva, L ;
Traina, M ;
Rizzo, A ;
Cottone, M .
DIGESTIVE AND LIVER DISEASE, 2004, 36 (12) :818-820
[7]   Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease [J].
de Francisco, Ruth ;
Castano-Garcia, Andres ;
Martinez-Gonzalez, Susana ;
Perez-Martinez, Isabel ;
Gonzalez-Huerta, Ana J. ;
Morais, Lucia R. ;
Fernandez-Garcia, Maria S. ;
Jimenez, Santiago ;
Diaz-Coto, Susana ;
Florez-Diez, Pablo ;
Suarez, Adolfo ;
Riestra, Sabino .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (07) :723-730
[8]   Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis [J].
Dignass, Axel ;
Eliakim, Rami ;
Magro, Fernando ;
Maaser, Christian ;
Chowers, Yehuda ;
Geboes, Karel ;
Mantzaris, Gerassimos ;
Reinisch, Walter ;
Colombel, Jean-Frederic ;
Vermeire, Severine ;
Travis, Simon ;
Lindsay, James O. ;
Van Assche, Gert .
JOURNAL OF CROHNS & COLITIS, 2012, 6 (10) :965-990
[9]   COURSE AND PROGNOSIS OF ULCERATIVE COLITIS [J].
EDWARDS, FC ;
TRUELOVE, SC .
GUT, 1963, 4 (04) :299-+
[10]   Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management (Publication with Expression of Concern) [J].
Harbord, Marcus ;
Eliakim, Rami ;
Bettenworth, Dominik ;
Karmiris, Konstantinos ;
Katsanos, Konstantinos ;
Kopylov, Uri ;
Kucharzik, Torsten ;
Molnar, Tamas ;
Raine, Tim ;
Sebastian, Shaji ;
de Sousa, Helena Tavares ;
Dignass, Axel ;
Carbonnel, Franck .
JOURNAL OF CROHNS & COLITIS, 2017, 11 (07) :769-784